Regulatory Recon: Vertex Stops Cystic Fibrosis Combination Trial After No Benefit Found Aurinia Lupus Drug Meets Endpoint Despite 13 Patient Deaths (16 August 2016)

ReconReconRegulatory NewsRegulatory News